WHO ICTRP trial
An unblinded, multi-center study evaluating long-term treatment with…
EUCTR2020-000547-31-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2020-000547-31-IT |
|---|---|
| Public title | An unblinded, multi-center study evaluating long-term treatment with Zanubrutinib (BGB-3111) regimens in patients with blood cancer in the lymph nodes |
| Scientific title | An Open-label, Multi-center, Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Patients with B cell Malignancies - n/a |
| Primary sponsor | BeiGene Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;Korea, Democratic People's Republic of;Australia;United Kingdom;New Zealand;China;Italy;Korea, Republic of |
| Conditions | B-cell malignancies MedDRA version: 20.0 Level: LLT Classification code 10003901 Term: B-cell lymphoma NOS System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Product Name: Zanubrutinib Product Code: [BGB-3111] Pharmaceutical Form: Capsule, hard INN or Proposed INN: Zanubrutinib CAS Number: 1691249-45-2 Current Sponsor code: BGB-3111 Concentration unit: mg milligram(s) Concentration type: equal… |
| Registration date | Oct 22, 2020 |
| Target size | 500 |
| Secondary IDs | BGB-3111-LTE1;Zanubrutinib;2020-000547-31-GB |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: